There are 2949 resources available
1435P - Survival of T1a of gastric signet ring cell carcinoma for guidance of safe endoscopic treatment: Analysis of Collaborative Stage Data of Korean Central Cancer Registry
Presenter: Hee Man Kim
Session: E-Poster Display
Resources:
Abstract
1436P - Comparison of perioperative chemotherapy versus postoperative chemoradiation therapy for operable stomach cancer: A western Canadian province experience
Presenter: Adnan Zaidi
Session: E-Poster Display
Resources:
Abstract
1438P - The outcome of neoadjuvant FLOT chemotherapy in East Sussex, UK: A comparison study to FLOT4
Presenter: Manivannan Periasamy
Session: E-Poster Display
Resources:
Abstract
1437P - Can FDG-PET predict early disease relapse in patients receiving peri-operative FLOT for localised oesophago-gastric adenocarcinoma?
Presenter: Pavetha Seeva
Session: E-Poster Display
Resources:
Abstract
1439P - Phase II study to evaluate feasibility and safety of oral nutritional supplementation with high density liquid diet after total gastrectomy for patients with gastric cancer
Presenter: Takanobu Yamada
Session: E-Poster Display
Resources:
Abstract
1440P - Safety and efficacy of FLOT regimen neoadjuvant treatment in Polish population: Interim analysis of prospective biomarker study
Presenter: Katarzyna Marcisz-Grzanka
Session: E-Poster Display
Resources:
Abstract
1441P - Outcomes of neoadjuvant chemoradiation (nCRT) +/- surgery and definitive CRT (dCRT) in a single institution using the CROSS trial regimen in esophageal (EC) and gastroesophageal junction cancer (GEJC) in Canada
Presenter: Sidra Khalid
Session: E-Poster Display
Resources:
Abstract
1442P - Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro + chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062
Presenter: Lucjan Wyrwicz
Session: E-Poster Display
Resources:
Abstract
1443P - Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction – Safety Results from AIO-STO-0417: A randomized phase II trial of the German Gastric Group of the AIO
Presenter: Claudia Pauligk
Session: E-Poster Display
Resources:
Abstract
1444P - Real-world nivolumab safety data from 650 patients with unresectable advanced or recurrent gastric cancer that had progressed after cancer chemotherapy: Summary of post-marketing surveillance in Japan
Presenter: Narikazu Boku
Session: E-Poster Display
Resources:
Abstract